These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 67419)

  • 21. Sub-acute myelo-optico neuropathy (a case report).
    Mathew R; Gupta PS
    J Assoc Physicians India; 1978 Jun; 26(6):547-8. PubMed ID: 152755
    [No Abstract]   [Full Text] [Related]  

  • 22. The neurotoxicity of the halogenated hydroxyquinolines. A commentary.
    Oakley GP
    JAMA; 1973 Jul; 225(4):395-7. PubMed ID: 4270059
    [No Abstract]   [Full Text] [Related]  

  • 23. The aetiology of SMON may involve an interaction between clioquinol and environmental metals.
    Tjälve H
    Med Hypotheses; 1984 Nov; 15(3):293-9. PubMed ID: 6240588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A iatrogenic disease... subacute myelo-optico-neuropathy].
    Degos CF; Thomas-Lamotte PJ
    Rev Prat; 1977 Jun; 27(35):2277-85. PubMed ID: 143057
    [No Abstract]   [Full Text] [Related]  

  • 25. Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey.
    Nakae K; Yamamoto S; Shigematsu I; Kono R
    Lancet; 1973 Jan; 1(7796):171-3. PubMed ID: 4118793
    [No Abstract]   [Full Text] [Related]  

  • 26. [Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)].
    Charasz N; Vacherot B; Dougados M; Bousser MG; Belaiche J; Cattan D
    Gastroenterol Clin Biol; 1979 Apr; 3(4):371-4. PubMed ID: 159200
    [No Abstract]   [Full Text] [Related]  

  • 27. Halogenated oxyquinoline derivatives and neurological syndromes.
    Shimada Y; Tsuji T; Igata A; Steinitz H
    Lancet; 1971 Jul; 2(7714):41-3. PubMed ID: 4103679
    [No Abstract]   [Full Text] [Related]  

  • 28. More on S.M.O.N.
    Lancet; 1971 Dec; 2(7736):1244. PubMed ID: 4143604
    [No Abstract]   [Full Text] [Related]  

  • 29. Myelopathy after clioquinol treatment.
    Osterman PO
    Lancet; 1971 Sep; 2(7723):544. PubMed ID: 4105685
    [No Abstract]   [Full Text] [Related]  

  • 30. Clioquinol intoxication occurring in the treatment of acrodermatitis enteropathica with reference to SMON outside of Japan.
    Hanakago R; Uono M
    Clin Toxicol; 1981 Dec; 18(12):1427-34. PubMed ID: 6460590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S.M.O.N.
    Spillane JD
    Lancet; 1972 Jan; 1(7742):154. PubMed ID: 4109013
    [No Abstract]   [Full Text] [Related]  

  • 32. Clioquinol's return: cautions from Japan.
    Tabira T
    Science; 2001 Jun; 292(5525):2251-2. PubMed ID: 11424945
    [No Abstract]   [Full Text] [Related]  

  • 33. [SMON syndrome. First case after abuse of a methylated hydroxyquinoline derivative].
    Saragoussi JJ; Soffer M; Giraud D; Raison J; Basdevant A; Pouliquen Y
    Bull Soc Ophtalmol Fr; 1984 Jan; 84(1):25-8. PubMed ID: 6442219
    [No Abstract]   [Full Text] [Related]  

  • 34. [Serious sensory-motor neuropathy. A case of renal failure following clioquinol absorption].
    Gendre JP; Barbanel C; Degos JD; Le Quintrec Y
    Nouv Presse Med; 1974 Nov; 3(37):2395-8. PubMed ID: 4282135
    [No Abstract]   [Full Text] [Related]  

  • 35. [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3].
    Aoyama H; Oira M; Ota T; Yoshioka S; Yoshida T
    Nihon Eiseigaku Zasshi; 1970 Dec; 25(5):468-71. PubMed ID: 4251106
    [No Abstract]   [Full Text] [Related]  

  • 36. [Case of subacute myelo-optico-neuropathy].
    Mackiewicz J; Wendorff J
    Neurol Neurochir Pol; 1980; 14(1):121-3. PubMed ID: 6445513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subacute myelo-optic neuropathy in Australia.
    Selby G
    Lancet; 1972 Jan; 1(7742):123-5. PubMed ID: 4108984
    [No Abstract]   [Full Text] [Related]  

  • 38. Is there SMON in India?
    Wadia NH
    Neurol India; 1973 Sep; 21(3):95-103. PubMed ID: 4274127
    [No Abstract]   [Full Text] [Related]  

  • 39. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)].
    Bron HL; Korten JJ; Pinckers AJ; Majoor CL
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825
    [No Abstract]   [Full Text] [Related]  

  • 40. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].
    Inoue N; Kuroiwa Y; Ikeda M; Yasukouchi T
    Rinsho Shinkeigaku; 1974 Oct; 14(10):769-73. PubMed ID: 4282713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.